In lung cancer, MALAT1 promotes metastatic spread, EMT, and resistance to chemotherapy and targeted therapies, highlighting its prognostic value and therapeutic potential in advanced-stage disease [229]. This evidence concerns the gene MALAT1 and lung carcinoma.